Cisplatin

major vault protein ; Homo sapiens







23 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30336197 Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells. 2019 Jan 1
2 31044552 IL-25 promotes cisplatin resistance of lung cancer cells by activating NF-κB signaling pathway to increase of major vault protein. 2019 Jul 3
3 29257330 Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc. 2018 Mar 2
4 30288106 S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism. 2018 1
5 28597042 Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells. 2017 Aug 2
6 27330316 Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression. 2016 4
7 26710702 [Influence and mechanism of PinX1 gene on the chemotherapy sensitivity of nasopharyngeal carcinoma cells in response to Cisplatin]. 2015 Jun 23 1
8 21793937 The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma. 2012 Feb 1
9 22989452 [Effect of Src tyrosine kinase inhibition on the drug-resistance as well as MDR1 and LRP expression of the human cis-platinum-resistant lung cancer cell line A549/DDP]. 2012 Sep 3
10 19875192 Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy. 2010 Jul 1
11 19900859 Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival. 2009 Nov 1
12 16364413 Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells. 2006 Jul 5
13 16465425 Direct activation of the human major vault protein gene by DNA-damaging agents. 2006 Mar 2
14 15547764 Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines. 2004 Dec 9
15 12520742 [Expression of lung resistant-related protein in ovarian cancer and its clinical significance]. 2002 Dec 4
16 11745417 Overexpression of the human major vault protein in astrocytic brain tumor cells. 2001 Nov 1 1
17 11004683 Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs. 2000 Oct 15 1
18 11372415 [Establishment of cisplatin-induced multidrug resistant human epithelial ovarian cancer cell line 3AO/cDDP and its expressions of multidrug resistance proteins]. 2000 Oct 1
19 9667676 A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer. 1998 Jun 2
20 9713513 Lung resistance-related protein gene expression and drug sensitivity in human gastric and lung cancer cells. 1998 Jul-Aug 2
21 9737684 Lung resistance protein (LRP) gene expression in adult acute myeloid leukemia: a critical evaluation by three techniques. 1998 Sep 1
22 9570378 Advanced non-small cell lung cancer chemotherapy: a randomized trial of two active regimens (MVP and PE). 1997 Nov 11 1
23 3940622 Phase II evaluation of a combination of mitomycin C, vincristine, and cisplatin in advanced non-small cell lung cancer. 1986 Jan 1 1